Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| amacrine cell | 4 studies | 40% ± 18% | |
| retinal bipolar neuron | 4 studies | 36% ± 18% | |
| endothelial cell | 3 studies | 35% ± 12% | |
| retinal cone cell | 3 studies | 49% ± 22% | |
| retinal rod cell | 3 studies | 38% ± 26% | |
| mucus secreting cell | 3 studies | 44% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 3 studies | 40% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 380.27 | 653 / 653 | 39% | 0.64 | 234 / 605 |
| brain | 100% | 369.17 | 2636 / 2642 | 38% | 0.61 | 265 / 705 |
| esophagus | 95% | 1307.26 | 1376 / 1445 | 42% | 0.84 | 77 / 183 |
| adrenal gland | 100% | 445.78 | 258 / 258 | 35% | 0.56 | 81 / 230 |
| kidney | 100% | 258.54 | 89 / 89 | 34% | 0.65 | 309 / 901 |
| breast | 100% | 420.20 | 459 / 459 | 34% | 0.75 | 377 / 1118 |
| lung | 99% | 1401.58 | 573 / 578 | 34% | 0.76 | 388 / 1155 |
| prostate | 100% | 443.52 | 245 / 245 | 32% | 0.62 | 161 / 502 |
| pancreas | 88% | 134.88 | 290 / 328 | 39% | 0.65 | 70 / 178 |
| intestine | 99% | 239.65 | 961 / 966 | 28% | 0.57 | 145 / 527 |
| bladder | 100% | 247.71 | 21 / 21 | 23% | 0.41 | 114 / 504 |
| stomach | 97% | 194.02 | 350 / 359 | 24% | 0.50 | 70 / 286 |
| uterus | 100% | 401.15 | 170 / 170 | 22% | 0.39 | 100 / 459 |
| skin | 99% | 951.91 | 1792 / 1809 | 22% | 0.41 | 105 / 472 |
| ovary | 100% | 390.03 | 180 / 180 | 20% | 0.33 | 84 / 430 |
| liver | 97% | 170.37 | 220 / 226 | 7% | 0.10 | 27 / 406 |
| spleen | 100% | 299.70 | 241 / 241 | 0% | 0 | 0 / 0 |
| adipose | 100% | 281.00 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 247.03 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 98% | 194.10 | 785 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 191.16 | 831 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 41% | 65.92 | 380 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 0.15 | 4 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 11% | 0.14 | 5 / 45 |
| eye | 0% | 0 | 0 / 0 | 5% | 0.06 | 4 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007601 | Biological process | visual perception |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PRR4 |
| Protein name | Proline-rich protein 4 (Salivary acidic proline-rich phosphoprotein 1/2) Proline-rich protein 4 Proline rich 4 (Proline-rich protein 4) Proline-rich protein 4 (Lacrimal proline-rich protein) (Nasopharyngeal carcinoma-associated proline-rich protein 4) |
| Synonyms | LPRP PROL4 PRH1 |
| Description | |
| Accessions | ENST00000614435.2 [Q16378-1] A0A0J9YXF8 ENST00000633483.1 ENST00000228811.8 [Q16378-1] ENST00000544994.5 [Q16378-2] A0A0A0MT31 ENST00000613368.2 ENST00000576999.5 [Q16378-2] F5H178 ENST00000574424.5 [Q16378-1] ENST00000543480.3 ENST00000632373.1 [Q16378-2] ENST00000574037.1 Q16378 ENST00000540107.2 ENST00000631790.1 |
